Mr Tomasz Kaczyński > Domanski Zakrzewski Palinka > Warsaw, Poland > Lawyer Profile

Domanski Zakrzewski Palinka

Work Department

Life Sciences


Partner in Life Sciences Practice. His expertise encompasses all areas of pharmaceutical law – product registration, reimbursement issues, manufacturing, distribution, parallel import, advertising law and clinical trial issues – he focuses particularly on creating distribution structure in the pharmaceutical market. Advises over 40 companies operating on the pharmaceutical market, including manufacturers, distributors and pharmacy chains. Specialises in food law, in particular regulations applicable to FSMP and dietary supplements. Advises clients on structuring distribution strategies, preventing antitrust agreements and abuse of dominant position, consumer protection law, and combating unfair competition. His experience also includes advising clients on the feed market and GMO food regulation and participation in inspection proceedings on the agri- food market. Previously he worked on public health issues in local administrative authorities where he was responsible e.g. for restructuring public health care centres in Mazowieckie Voivodship.


Polish and English


Expert Council Member in the Polish Council for Supplements and Nutritional Foods (KRSiO).
Member of the Regional Chamber of Legal Advisers in Warsaw.

Lawyer Rankings

Poland > Healthcare and life sciences

(Leading individuals)

Tomasz KaczyńskiDomanski Zakrzewski Palinka

Domanski Zakrzewski Palinka‘s life sciences practice has ‘exceptional pharmaceutical market knowledge‘. The team provides daily legal support to its clients, as well as advising on projects, strategic matters, M&A transactions and regulatory issues. The team benefits from the strength of the firm’s M&A, IP, infrastructure, capital markets, labour law and dispute resolution teams. Michał Czarnuch leads the group with expertise in healthcare law. ‘Excellent advisor’ Tomasz Kaczyński has extensive experience in the pharmaceutical industry, Anna Partyka-Opiela acts as an in-house counsel for pharmaceutical companies and Marcin Pieklak advises clients on the financing of drugs, medical devices and food supplements from public funds.